These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 629974)

  • 1. A conformational basis for the antiviral inactivity of tetrazole ribonucleosides.
    Miles DL; Miles DW; Eyring H
    Biochim Biophys Acta; 1978 Mar; 518(1):17-30. PubMed ID: 629974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theoretical studies of the conformational properties of ribavirin.
    Miles DL; Miles DW; Redington P; Eyring H
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4257-60. PubMed ID: 1069980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational analysis of nucleoside and nucleotide antibiotics prossessing five-membered base rings. A comparison of the glycosyl barrier for purine, pyrimidine and imidazole rings.
    Vijayaiakshmi KS; Yathindra N
    Biochim Biophys Acta; 1980 Mar; 607(1):171-80. PubMed ID: 7370262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
    Franchetti P; Grifantini M
    Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of tetrazole ribonucleosides and their evaluation as antiviral agents. 2. 5-Amino-1-(beta-D-ribofuranosyl)-1H-tetrazole and 5-amino-2-(beta-D-ribofuranosyl)-2H-tetrazole.
    Poonian MS; Nowoswiat EF; Blount JF; Kramer MJ
    J Med Chem; 1976 Aug; 19(8):1017-20. PubMed ID: 966248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of tetrazole ribonucleosides and their evaluation as antiviral agents.
    Poonian MS; Nowoswiat EF; Blount JF; Williams TH; Pitcher RG; Kramer MJ
    J Med Chem; 1976 Feb; 19(2):286-90. PubMed ID: 1249809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of a circular dichroism and theoretical investigation of ribavirin-related derivatives in drug design.
    Miles DL; Miles DW; Eyring H
    Ann N Y Acad Sci; 1981; 367():518-30. PubMed ID: 6114699
    [No Abstract]   [Full Text] [Related]  

  • 8. Substitution of the conserved Arg-Tyr dyad selectively disrupts the hydrolysis phase of the IMP dehydrogenase reaction.
    Guillén Schlippe YV; Riera TV; Seyedsayamdost MR; Hedstrom L
    Biochemistry; 2004 Apr; 43(15):4511-21. PubMed ID: 15078097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMP dehydrogenase and action of antimetabolites in human cultured blast cells.
    Yamada Y; Goto H; Yoshino M; Ogasawara N
    Biochim Biophys Acta; 1990 Mar; 1051(3):209-14. PubMed ID: 1968764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [IMP dehydrogenase].
    Yamaoka T
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():59-65. PubMed ID: 12629691
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
    Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-based design of inosine 5-monophosphate dehydrogenase inhibitors: synthesis and biological activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives.
    Minakawa N; Matsuda A
    Curr Med Chem; 1999 Jul; 6(7):615-28. PubMed ID: 10390604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the permeation of dihexadecyl phosphate vesicles by various carboxylic acids and some of their tetrazole analogues.
    Pernice P; Castaing M; Ménassa P; Kraus JL
    Biophys Chem; 1988 Oct; 32(1):15-20. PubMed ID: 3233310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents.
    Stuyver LJ; Lostia S; Patterson SE; Clark JL; Watanabe KA; Otto MJ; Pankiewicz KW
    Antivir Chem Chemother; 2002 Nov; 13(6):345-52. PubMed ID: 12718406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acyclic analogs of ribavirin. Synthesis and antiviral activity].
    Tsilevich TL; Shchaveleva IL; Nosach LN; Zhovnovataia VL; Smirnov IP
    Bioorg Khim; 1988 May; 14(5):689-93. PubMed ID: 3422011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine kinase initiates the major route of ribavirin activation in a cultured human cell line.
    Willis RC; Carson DA; Seegmiller JE
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3042-4. PubMed ID: 210448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of erythroid differentiation in K562 cells by inhibitors of inosine monophosphate dehydrogenase.
    Yu J; Lemas V; Page T; Connor JD; Yu AL
    Cancer Res; 1989 Oct; 49(20):5555-60. PubMed ID: 2571408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
    Jayaram HN; Cooney DA; Grusch M; Krupitza G
    Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic mechanism of human inosine 5'-monophosphate dehydrogenase type II: random addition of substrates and ordered release of products.
    Wang W; Hedstrom L
    Biochemistry; 1997 Jul; 36(28):8479-83. PubMed ID: 9214292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study by circular dichroism of the conformation of deazapurine nucleosides and that of common purine nucleosides.
    Miles DW; Townsend LB; Redington P; Eyring H
    Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2384-7. PubMed ID: 1065890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.